Abbott Laboratories has fended off patent infringement claims filed by Enzo Biochem after convincing a US court that the patents did not describe the invention in a sufficient way.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Enzo, Abbott, patents, RealTime, FISH, diagnostics, DNA
